Ten-year follow-up of a randomized controlled trial comparing saphenofemoral ligation and stripping of the great saphenous vein with endovenous laser ablation (980 nm) using local tumescent anesthesia

Eggen, C.A.M.; Alozai, Tamana; Pronk, Pascal; Mooij, Michael C.; Gaastra, Menno; Ünlü, Çağdaş; Schreve, Michiel A; Vlijmen, Clarissa J. van

doi:10.1016/j.jvsv.2021.08.008

Cited by 17 publications

(3 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Wallece et al described tumescent anesthesia to avoid thermal injury. Eggen et al stated that the use of tumescent anesthesia during endovenous thermal ablation in 62 patients was a simple, safe, inexpensive, and effective way to reduce perioperative and early postoperative pain [19,20].…”

Section: Discussionmentioning

confidence: 99%

Evaluating endovenous laser and glue ablation in the treatment of great saphenous vein insufficiency: A 5-year retrospective comparative study

Guven

2023

Turk J Vasc Surg

View full text Add to dashboard Cite

Aim: The use of endovascular thermal and nonthermal methods in the treatment of chronic venous insufficiency has been in practice for over 10 years. The early results of these practices have been published and extensively discussed. Medium and long-term results are now being announced. In our study, we discussed the results of endovenous laser ablation and endovenous glue ablation methods, along with hemodynamic evaluations. Material and Methods: Doppler USG and Digital Photo Plethysmography were used to examine patients with chronic venous insufficiency in the C2-5 group who received endovenous ablation indication. Records of VCSS and CIVIQ-20 were obtained. Measurements were taken at 1, 3, 6, 12, 24, and 60 months. Procedural and post-procedural variables were compared, and the results were obtained for a 5-year period. Results: The demographic profiles of the groups were similar. The duration of the procedure was significantly longer in the EVLA group. Similarly, the pain during the procedure was statistically significantly higher in the EVLA group. Venous refill time and venous half-life time showed a statistically significant improvement in both groups. While there were close to 100% closure rates in both groups during the first 6 months, the rates decreased to 95.2% in EVLA and 93.5% in EVGA by the end of the fifth year. Conclusion: With 5 years of objective and subjective findings, both EVLA and EVGA are effective and reliable methods with their advantages and disadvantages. However, EVGA may be more preferred by patients because it does not require tumescent anesthesia, causes less pain, and has a shorter procedure time.

show abstract

Section: Discussionmentioning

confidence: 99%

Evaluating endovenous laser and glue ablation in the treatment of great saphenous vein insufficiency: A 5-year retrospective comparative study

Guven

2023

Turk J Vasc Surg

View full text Add to dashboard Cite

show abstract

“…Die moderne Varizenchirurgie wird diesem Anspruch gerecht. Im Vergleich zu den konkurrierenden interventionellen Verfahren weist die Varizenoperation signifikant niedrigere Raten echter Rezidive (Same-Site-Rezidive) auf [5,6,7]. In einer aktuellen Metaanalyse verglichen Gasior et al [8]…”

Section: Aus Der Sicht Von Patienten Hat Die Rezidivfreiheit Eine Hoh...unclassified

Antwort zum Leserbrief: Recrossektomie und Barrier-Implantation

Mumme

2022

Phlebologie

View full text Add to dashboard Cite

Sehr geehrter Herr Kollege Fuchs, wir freuen uns über Ihren Leserbrief zu unserer Publikation "Recrossektomie und Barrier-Implantation" [1]. Entsprechend den Anforderungen des Formats "Fortbildung in Bildern" sollte die Technik der Barriere-Operation anschaulich dargestellt werden. Selbstverständlich konnten dabei nicht alle Aspekte des komplexen Themas der Rezidivvarikose angesprochen werden. Gerne greifen wir die Gelegenheit des Leserbriefes auf, um offen gebliebene Fragen zu erläutern. PublikationshinweisLeserbriefe stellen nicht unbedingt die Meinung von Herausgebern oder Verlag dar. Herausgeber und Verlag behalten sich vor, Leserbriefe nicht, gekürzt oder in Auszügen zu veröffentlichen.

show abstract

“…The paucity of this data may be explained by the currently high success rates of most endovenous treatment modalities, such as endovenous laser ablation (EVLA) and radiofrequency ablation (RFA). 7 Although long-term data on QoL of patients with recurrence varicose veins is available, 8 this data can be negatively influenced by clinical progression of their chronic venous disease or comorbidities. Additionally, in the past, criteria for closure failure at duplex ultrasound (DUS) were not uniform which limits the ability to compare studies.…”

Section: Introductionmentioning

confidence: 99%

A comparison of patient-reported outcome measures following technical success and technical failure in the treatment of great saphenous vein incompetence using ClariVein: A subanalysis of a multicenter randomized controlled trial comparing 2% and 3% polidocanol

et al. 2023

View full text Add to dashboard Cite

Objective This study aimed to compare patient-reported outcomes after technical success (TS) and technical failure (TF) in treating great saphenous vein incompetence (GSV) with ClariVein. Methods A subanalysis of a previous trial was conducted on symptomatic GSV incompetence patients who received ClariVein treatment with 2% or 3% polidocanol (POL) and were followed for 6 months. Blinding was implemented for observers and patients, and data from both POL groups were combined. TS was defined as at least 85% occlusion of the treated vein, while TF indicated failure to meet TS criteria. Secondary outcomes included Venous Clinical Severity Score (VCSS), Aberdeen Varicose Vein Questionnaire (AVVQ), and Short-Form 36 Health Survey Questionnaire (SF-36). Results Among the 364 patients included, the TS rate was 64.5%. Comparison of VCSS, AVVQ, and SF-36 scores between TS and TF groups did not yield significant differences. Conclusion This study indicates no significant variation in VCSS, AVVQ, and SF-36 scores between patients experiencing TS and TF following ClariVein treatment for GSV insufficiency.

show abstract

Ten-year follow-up of a randomized controlled trial comparing saphenofemoral ligation and stripping of the great saphenous vein with endovenous laser ablation (980 nm) using local tumescent anesthesia

Cited by 17 publications

References 23 publications

Evaluating endovenous laser and glue ablation in the treatment of great saphenous vein insufficiency: A 5-year retrospective comparative study

Evaluating endovenous laser and glue ablation in the treatment of great saphenous vein insufficiency: A 5-year retrospective comparative study

Antwort zum Leserbrief: Recrossektomie und Barrier-Implantation

A comparison of patient-reported outcome measures following technical success and technical failure in the treatment of great saphenous vein incompetence using ClariVein: A subanalysis of a multicenter randomized controlled trial comparing 2% and 3% polidocanol

Contact Info

Product

Resources

About